Clik here to view.
インヴィクロがCOVID-19研究のための医用画像データセットのリポジトリー開設へ
ボストン （ビジネスワイヤ） — コニカミノルタ子会社のインヴィクロは、マイクロソフトと協力して、COVID-19診断用CT／X線画像データセットの無料リポジトリーを作成し、この世界的な脅威に対する理解と対処の促進に当たっています。本リポジトリーでは、インヴィクロのiPACS®およびMicrosoft...
View ArticleClik here to view.
CANbridge Pharmaceuticals Receives Marketing Approval for NERLYNX®...
BEIJING & SHANGHAI CANbridge Pharmaceuticals Inc., a biopharmaceutical company developing innovative drug candidates to treat underserved medical conditions in China and other markets, announced...
View ArticleClik here to view.
HighTide Therapeutics Announces Positive Topline Results From Phase 2a Study...
SHENZHEN, China & ROCKVILLE, Md. HighTide Therapeutics Inc. (“HighTide”), a clinical-stage biopharmaceutical company, today announced topline results of the study of HTD1801 in 100 adults with...
View ArticleClik here to view.
Gilead Announces Approval of Veklury® (remdesivir) in Japan for Patients With...
FOSTER CITY, Calif. Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has granted regulatory approval of Veklury® (remdesivir) as a...
View ArticleClik here to view.
ENHERTU® Granted Breakthrough Therapy Designation in the U.S. for HER2...
TOKYO, BASKING RIDGE, N.J. & MUNICH Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) and AstraZeneca’s ENHERTU® (fam-trastuzumab deruxtecan-nxki) has been granted Breakthrough Therapy...
View ArticleClik here to view.
AVITA Medical Limited Proposed redomiciliation to the United States of...
VALENCIA, Calif. & MELBOURNE, Australia AVITA Medical Limited (Company) (ASX:AVH, NASDAQ:RCEL) is pleased to announce that the Federal Court of Australia (Court) has today approved orders to...
View ArticleClik here to view.
Frazier Healthcare Partners Launches Lengo Therapeutics
MENLO PARK, Calif. & BANGALORE, India Frazier Healthcare Partners (“Frazier”) today announced the launch of Lengo Therapeutics, Inc. (“Lengo”), a biopharmaceutical company focused on the...
View ArticleClik here to view.
Legend Biotech and Noile-Immune Biotech Announce Collaborative Research and...
SOMERSET, N.J., USA and TOKYO, Japan Legend Biotech Corporation (“Legend”), a global clinical stage biopharmaceutical company engaged in the discovery and development of novel cell therapies,...
View ArticleClik here to view.
What Biopharma Needs, BIO KOREA 2020 International Convention Delivers Online
CHEONGJU, South Korea The BIO KOREA Organizing Committee announced it will hold the BIO KOREA 2020 International Convention scheduled for May 18–23 as an online convention instead of an in-person...
View ArticleClik here to view.
Takeda Accelerates Transformation: Solid FY2019 Results, Confidence in FY2020...
OSAKA, Japan Takeda Pharmaceutical Company Limited (TOKYO: 4502) (NYSE: TAK) (“Takeda”) today announced financial results for the year ended March 31, 2020 (FY2019). As a top 10 global...
View ArticleClik here to view.
Clik here to view.
Modulus Discovery Closes $25.5M USD Series B
TOKYO Modulus Discovery, Inc., a preclinical-stage technology-driven drug discovery firm, announces the successful closing of its series B funding round in the amount of 2.71 B JPY (approximately...
View ArticleClik here to view.
BIO KOREA 2020国际大会将以在线方式满足生物制药业的所有需求
韩国清州 (美国商业资讯)–韩国生物产业博览会(BIO KOREA)组委会宣布，今年的BIO KOREA 2020国际大会将于5月18日至23日以在线而非现场方式举行。 组委会是因为考虑到COVID-19的影响、与会人员的安全以及有关大型现场聚会的全球健康建议而做出这一决定的。 BIO KOREA 2020在线大会 日期：5月18日09:00至23日18:00（韩国标准时）...
View ArticleClik here to view.
China NMPA Approves Optune® for the Treatment of Newly Diagnosed and...
ST. HELIER, Jersey & SHANGHAI Novocure (NASDAQ: NVCR), a global oncology company with a proprietary platform therapy called Tumor Treating Fields, and Zai Lab Limited (NASDAQ: ZLAB), an...
View ArticleClik here to view.
AVITA Medical to Participate at Oppenheimer’s MedTech Summit
VALENCIA, Calif. & MELBOURNE, Australia AVITA Medical Limited (Company) (ASX:AVH) (NASDAQ:RCEL) today announced that management will participate virtually in the 1-on-1 meetings at the upcoming...
View ArticleClik here to view.
The Ajinomoto Group Introduces a Nutrient Profiling System
TOKYO Ajinomoto Co., Inc. (“Ajinomoto Co.”) will roll out its nutrition improvement activities globally with the introduction on April 1, 2020 of the Ajinomoto Group Nutrient Profiling System for...
View ArticleClik here to view.
European Commission Approves ADCETRIS® (brentuximab vedotin) for Treatment of...
CAMBRIDGE, Mass. & OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that the European Commission (EC) extended the current conditional marketing...
View ArticleClik here to view.
Takeda to Present Data at Upcoming Virtual Scientific Congresses,...
CAMBRIDGE, Mass. & OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE: 4502/NYSE:TAK) (“Takeda”) today announced that the company will present data from its expanding oncology pipeline and...
View ArticleClik here to view.
Arctic Vision Announces Formation of Scientific Advisory Board
SHANGHAI Arctic Vision, a clinical stage biotechnology company focusing on the development and commercialization of innovative ophthalmology therapies in China and Asia, announced today the...
View ArticleClik here to view.
武田加速转型：2019财年业绩稳健，对2020财年发展态势充满信心
日本大阪 (美国商业资讯)–武田药品工业株式会社(Takeda Pharmaceutical Company Limited) (TOKYO: 4502) (NYSE: TAK)（简称“武田”）今日宣布了截至2020年3月31日（2019财年）的全年业绩。作为全球排名前十的研发驱动型生物制药公司，武田在应对新冠疫情以及自身长期成功定位方面展现了其创新和价值。...
View Article